Genetic testing company 23andMe has leased office space in Palo Alto after abandoning its larger headquarters complex in Sunnyvale. The firm, which filed for Chapter 11 bankruptcy last year, leased 19 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The genetic testing company's ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 23andMe bought high — as Covid ...
Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...
A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. How to conduct your own portfolio makeover ...
23andMe, a distressed genetic testing company that filed for bankruptcy this year, has received another potential lifeline. A bankruptcy judge approved the sale of the company’s assets and business ...
Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...
Wojcicki launched TTAM earlier this year with the specific goal of keeping 23andMe’s genetic data of about 15 million users out of the hands of third parties like biotech firm Regeneron, which bid ...
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. Related Articles Jill On Money: Can Trump cap ...
The company's assets include genetic data belonging to 15 million customers. A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization ...